Codes / ICD10CM / T64.83XS

T64.83XS Toxic effect of other mycotoxin food contaminants, assault, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

  • Toxic effect of other mycotoxin food contaminants, assault, sequela

Summary

This condition represents the residual or chronic health effects resulting from a prior toxic exposure to mycotoxins (excluding aflatoxin) in food, where the exposure was due to intentional harm by another party. Sequela refers to the long-term consequences of the initial acute or chronic toxicity, which may persist beyond the active phase of the assault-related poisoning.

Causes

The underlying cause is a prior assault involving exposure to mycotoxin-contaminated food, such as grains, nuts, or spices, intentionally provided or administered by another individual. The sequela arises from the body’s response to the initial toxic insult, which may include organ damage, chronic inflammation, or persistent functional impairment.

Risk Factors

  • History of assault involving contaminated food or substances.
  • Delayed or inadequate treatment of the initial toxic exposure.
  • Pre-existing conditions that increase susceptibility to long-term organ damage (e.g., liver or kidney disease).
  • Prolonged or high-dose exposure during the assault.

Symptoms

  • Chronic liver dysfunction or cirrhosis (if hepatotoxic mycotoxins were involved).
  • Persistent gastrointestinal issues (e.g., malabsorption, chronic pain).
  • Neurological deficits or cognitive impairment from neurotoxic mycotoxins.
  • Reduced immune function or recurrent infections.
  • Growth impairment in children (if exposure occurred during development).

Diagnosis

Diagnosis relies on correlating the sequela with a documented history of assault-related mycotoxin exposure. Clinical evaluation includes assessing residual organ function (e.g., liver or kidney tests), imaging studies (e.g., ultrasound or MRI), and ruling out other causes of the symptoms. Laboratory confirmation of the initial toxin is often not feasible for sequela, so history and clinical findings are primary.

Treatment Options

Management focuses on addressing the residual effects, such as:

  • Liver-protective therapies for hepatotoxicity.
  • Nutritional support for malabsorption or growth issues.
  • Rehabilitation for neurological or functional impairments.
  • Monitoring for late complications (e.g., cancer risk in chronic exposure).

Prognosis and Follow-Up

Prognosis depends on the severity of the initial exposure and the organs affected. Some sequela may be irreversible, while others may stabilize with treatment. Long-term follow-up is essential to monitor for delayed complications, adjust therapies, and address psychosocial impacts of the assault.

Complications

  • Progressive organ failure (e.g., liver or kidney).
  • Increased risk of malignancies (e.g., liver cancer from chronic mycotoxin exposure).
  • Permanent neurological damage.
  • Psychological trauma related to the assault.

Lifestyle & Prevention

  • Avoid re-exposure to potentially contaminated foods.
  • Follow a balanced diet to support organ recovery.
  • Engage in mental health support to address trauma.
  • Regular medical monitoring to detect late complications early.

When to Seek Professional Help

Seek care if new or worsening symptoms emerge (e.g., jaundice, unexplained weight loss, or neurological changes) or if psychosocial impacts of the assault interfere with daily life.

Tips for Medical Coders

Use T64.83XS for sequela of toxic effect of other mycotoxin food contaminants due to assault. Document the link between the sequela and the prior assault-related exposure clearly. Ensure the sequela is distinct from active toxicity and specify the affected body part or system if applicable.

Book a walkthrough

T64.83XS policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.